Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer
KREISBERG, Jeffrey I, MALIK, Shazli N, PRIHODA, Thomas J, BEDOLLA, Roble G, TROYER, Dean A, KREISBERG, Suzanne, GHOSH, Paramita M
Published in Cancer research (Chicago, Ill.) (01.08.2004)
Published in Cancer research (Chicago, Ill.) (01.08.2004)
Get full text
Journal Article